FundedIQ
Biotechnology

EnginZyme: Funding, Investors & Team (Oct 2026)

Our ambition is to play a key role in tackling climate change, by enabling green chemistry for every industry. We do this by creating the most general and efficient technology platform for chemical production that the world has ever seen. That’s a big claim, but we can stand behind it. By bio-upgrading the chemical industry with our cell-free biomanufacturing platform, we can produce the products that modern society relies on in a truly sustainable way. The technology platform utilises nature’s catalysts, enzymes, by combining the power of biology with the efficiency of the chemical industry in a best-of-both-worlds solution. EnginZyme is recognised as a Technology Pioneer by World Economic Forum and backed by Sofinnova Partners, Industrifonden and SEB Greentech VC.

enginzyme.com LinkedIn Stockholm, Sweden 51-100 employees Founded 2014
Biotechnology GreenTech Life Science Manufacturing B2B Biochemistry Biocatalysis Bioinformatics
Total raised
$35.6M
Rounds
4
Latest
Undisclosed round
Sep 2026

EnginZyme has raised $35.6M across 4 funding rounds on record, the most recent an undisclosed round of $7.6M announced in Sep 2026.

That round is in line with the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.

EnginZyme Company Profile and Key Stats

Total funding raised
$35.6M
across 4 rounds on record
Funding rounds on record
4
1 with no disclosed amount
Latest funding round
Undisclosed round
$7.6M in Sep 2026
Employees
51-100
reported band
Founded
2014
Headquarters
Stockholm, Sweden
Investors on record
12
5 named below

Latest funding round on record: Sep 2026.

EnginZyme Funding Rounds

Date
Round
Amount
Undisclosed round
$7.6M
Undisclosed round
Undisclosed
Series B
$22.4M
Series A
$5.6M

1 of 4 rounds was announced without a disclosed amount and is excluded from the total.

EnginZyme raised $5.6M in a Series A announced in Feb 2021.

1.8 years later, a Series B of $22.4M was announced in Dec 2022.

1.8 years later, an undisclosed round was announced in Sep 2024 with no disclosed amount.

2 years later, an undisclosed round of $7.6M was announced in Sep 2026.

EnginZyme Investors

Lotus One Investment Sofinnova Partners Active Capital Navigare Ventures Industrifonden

12 investors are recorded in total; the 5 named above are those the record identifies.

EnginZyme Founders and Leadership Team

Name
Role
Contact
De Aymeric
Chief Executive Officer
Locked
Karim Engelmark Cassimjee
CEO
Locked

Contact details for the EnginZyme team: 2 of 2 have an email address on file, 1 has a LinkedIn profile.

Start 14-day free trial →

EnginZyme Funding Compared to Other Biotechnology Startups

Segment
Companies
Median round
4,185
$8.1M
696
$4.4M

EnginZyme's latest round of $7.6M is in line with the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.

Funded Startups Like EnginZyme in Biotechnology and Stockholm

Companies Similar to EnginZyme

Pixelgen Technologies, established in Sweden in 2020, focuses on the advancement of biomedical research and…

Series B $15.5M

Oblique Therapeutics is developing a new type of antibody-based medication for chronic pain and metastatic…

Undisclosed round $1.4M

Emulsi Biotech is a biotechnology company that develops lipid technology to deliver biologic drugs orally.

Pre-Seed $740k

Our vision is to develop and bring to the market safe and effective treatments for women specific diseases…

Undisclosed round $790k

OncoZenge is a Swedish pharmaceutical company. It develops better products for the supportive care of cancer…

Undisclosed round $1.6M

Elicera Therapeutics is a clinical stage immuno-oncology company developing cell and gene therapies for…

Undisclosed round $150k

Alligator Bioscience is an innovative research based biotech company focused on developing novel drugs for…

Undisclosed round $2.1M

Moleculent is dedicated to creating tech-based products that utilize fresh knowledge about the molecular…

Undisclosed round $20.0M

Bio-Works was established in 2006 and specializes in creating, producing, and distributing cutting-edge…

Undisclosed round $60k

Verigraft AB is a biotech company that creates personalized tissue-engineered transplants for use in…

Undisclosed round $11.9M

Lipum aims to eliminate or alleviate painful symptoms for millions of patients suffering from chronic…

Undisclosed round $9.3M

ArgusEye is a biotech firm that offers sensor solutions for instant identification of biological systems and…

Undisclosed round $7.4M

EnginZyme Funding FAQs

What does EnginZyme do?

Our ambition is to play a key role in tackling climate change, by enabling green chemistry for every industry. We do this by creating the most general and efficient technology platform for chemical production that the world has ever seen. That’s a big claim, but we can stand behind it. By bio-upgrading the chemical industry with our cell-free biomanufacturing platform, we can produce the products that modern society relies on in a truly sustainable way. The technology platform utilises nature’s catalysts, enzymes, by combining the power of biology with the efficiency of the chemical industry in a best-of-both-worlds solution. EnginZyme is recognised as a Technology Pioneer by World Economic Forum and backed by Sofinnova Partners, Industrifonden and SEB Greentech VC.

How much funding has EnginZyme raised?

EnginZyme has raised $35.6M across 4 rounds on record. The most recent is an undisclosed round of $7.6M announced in Sep 2026.

When did EnginZyme last raise funding?

EnginZyme's most recent funding round on record is an undisclosed round of $7.6M, announced in Sep 2026.

Who has invested in EnginZyme?

Investors on record for EnginZyme include Lotus One Investment, Sofinnova Partners, Active Capital, Navigare Ventures, Industrifonden. FundedIQ records 12 investors in total.

Who is the CEO of EnginZyme?

De Aymeric is listed as Chief Executive Officer at EnginZyme.

Where is EnginZyme headquartered?

EnginZyme is based in Stockholm, Stockholms Lan, Sweden.

How many employees does EnginZyme have?

EnginZyme is in the 51-100 employee band.

When was EnginZyme founded?

EnginZyme was founded in 2014.

How does EnginZyme's funding compare to other Biotechnology startups?

EnginZyme's latest round of $7.6M is in line with the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.

About FundedIQ's EnginZyme Funding Data

FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.

Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for EnginZyme is left off this page rather than filled in.

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.

Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.